Global Dietary Supplements Market Trends

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Dietary Supplements Market Size, Share, and Trends Analysis Report Trends

  • Food & Beverage
  • Upcoming Report
  • Nov 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

“Increasing Trend Towards Personalized Nutrition”

The dietary supplements market is witnessing significant growth, driven by rising health consciousness and a trend toward personalized nutrition. Consumers are increasingly seeking tailored supplements that meet their specific health needs, such as boosting immunity or enhancing athletic performance. For instance, companies such as Nutrigenomix offer genetic testing to provide personalized supplement recommendations based on an individual’s DNA. This trend reflects a broader shift towards customized health solutions, as consumers aim to optimize their wellness regimens. E-commerce platforms also play a crucial role in this growth, enabling easy access to a wide range of dietary supplements, further fueling demand for personalized nutrition solutions. As awareness of the benefits of dietary supplements continues to rise, the market is poised for further innovation and expansion.

Frequently Asked Questions

The market is segmented based on Segmentation, By Type (Vitamins, Minerals, Amino Acids, Enzymes, and Other Supplements), Mode of Application (Capsules, Powder, Liquids, Soft Gels, and Gel Caps), Functions (Additional Supplement, Medicinal Supplements, and Sports Nutrition), Category (Infant Dietary Supplements, Children Dietary Supplements, Adult Dietary Supplements, Pregnant Women Dietary Supplements, and Old-Aged Dietary Supplement) – Industry Trends and Forecast to 2031 .
The Global Dietary Supplements Market size was valued at USD 84.68 USD Billion in 2023.
The Global Dietary Supplements Market is projected to grow at a CAGR of 8.72% during the forecast period of 2024 to 2031.
The major players operating in the market include Abbott, GlaxoSmithKline plc, Bayer AG, Pfizer , ADM, and more,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.